Cyclophosphamide ‘not dead yet’ for ANCA-associated vasculitis
Philip Seo SAN DIEGO — Although fading from use in vasculitis management strategies, cyclophosphamide still offers several benefits for a minority of patients who are unable to switch to other therapies, according to a presenter at the 2019 Congress of Clinical Rheumatology West. “Cyclophosphamide is not dead yet,” Philip Seo, MD, MHS, director of the […]
Cyclophosphamide ‘not dead yet’ for ANCA-associated vasculitis Read More »